WEDNESDAY, Feb. 15, 2023 (HealthDay News) — Most people hospitalized for COVID-19 are taking months to bounce back, a new study confirms. More than 70% of patients reported experiencing lingering symptoms, including coughing, rapid or irregular heartbeat and breathlessness. About half had fatigue or physical limitations. All of these symptomsContinue Reading

MONDAY, Feb. 13, 2023 (HealthDay News) — The COVID-19 antiviral treatment Paxlovid continues to work against Omicron subvariants BA.4 and BA.5, new research shows. Researchers decided to study Paxlovid’s impact against severe illness and death because doctors have fewer treatment options for high-risk patients as the virus evolves. “We areContinue Reading

FRIDAY, Feb. 10, 2023 (HealthDay News) — Healthy young people who vape or smoke may be putting themselves at greater risk for developing severe COVID, new research finds. Both smoking tobacco and vaping electronic cigarettes may predispose people to increased inflammation, future development of severe COVID-19 and lingering cardiovascular complications,Continue Reading

THURSDAY, Feb. 9, 2023 (HealthDay News) — A single injection of an experimental biologic drug may cut in half your risk of hospitalization from COVID-19 infection, new clinical trial results show. Pegylated lambda interferon (PEG-lambda) proved effective against all COVID-19 variants encountered in this international study, including Omicron, according toContinue Reading

TUESDAY, Feb. 7, 2023 (HealthDay News) — Kidney disease patients on dialysis are 100 times more likely to contract a dangerous blood infection than people not receiving the treatment — and that risk is borne primarily by Hispanic and Black Americans, U.S. government health officials say. Hispanic patients are 40%Continue Reading